Top 5 Diversified Bank Companies To Own For 2014

Think of The Motley Fool as kind of your TiVo for investment conferences. We'll help you skip to the good parts and zip past all the rest.

There were definitely some good parts in what Keryx Biopharmaceuticals (NASDAQ: KERX  ) had to say at this week's Stifel Nicolaus Weisel Healthcare Conference in Boston. A lot was said, but here are the three highlights you'll want to know about.

1. Commercialization of Zerenex
Keryx submitted its New Drug Application, or NDA, for Zerenex in August for treating hyperphosphatemia in patients with chronic kidney disease, or CKD, on dialysis. While the company is waiting to find out whether the NDA has been accepted, most expect that it will. If so, the U.S. Food and Drug Administration should announce a decision on the drug by the third quarter of 2014.

In the meantime, Keryx is taking a two-pronged approach. CEO Ron Bentsur said that the company is having "good development dialogue." By that, he undoubtedly means that Keryx is in the middle of conversations with possible commercialization partners for Zerenex. Bentsur didn't mention any names, though.

Top 10 Regional Bank Stocks To Invest In 2015: Conatus Pharmaceuticals Inc (CNAT)

Conatus Pharmaceuticals Inc., incorporated on July 13, 2005, is a biotechnology company focused on the development and commercialization of medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. The Company has designed a clinical program to demonstrate the therapeutic benefit of emricasan across the spectrum of fibrotic liver disease. The Company�� initial development strategy targets indications for emricasan with high unmet clinical need in orphan patient populations, such as patients with acute-on-chronic liver failure (ACLF), chronic liver failure (CLF), and patients who have developed liver fibrosis post-orthotopic liver transplant due to Hepatitis C virus infection (HCV-POLT).

The Company has completed two placebo-controlled Phase II trials in patients with liver disease showing reductions in ALT levels that occur rapidly, within as little as one day after initiation of therapy, and are maintained throughout the treatment period. In the Company�� 204-patient Phase 2b trial, it also measured cCK18, an important biomarker of apoptosis and disease severity. Emricasan has been generally well-tolerated in all of the clinical studies. As of July 23, 2013, the Company had not generated any revenue.

Advisors' Opinion:

• [By John Udovich]

  Recent IPO�FibroGen Inc (NASDAQ: FGEN) surged 22.96% today, reportedly after the journal Hepatology published the results of a workshop between the FDA and the American Association for the Study of Liver Disease (AASLD) which laid out criteria for a phase three study of a treatment for non-alcoholic steatohepatitis (NASH)���meaning its worth taking a closer look at the stock along with the performance of potential small cap or mid cap liver disease stock peers like Conatus Pharmaceuticals Inc (NASDAQ: CNAT), Intercept Pharmaceuticals Inc (NASDAQ: ICPT) and Raptor Pharmaceutical Corp (NASDAQ: RPTP) which rose 24.35%, 10.98% and 2.02%, respectively. According to Investors Business Daily, NASH (the more serious version of fatty liver disease) is potentially an enormous market with about 6 million�US patients but the�lack of previous treatments had left it unclear how the FDA would measure success against the disease while FibroGen Inc doesn't yet have a NASH human trial in the works, it has said it hopes to start one for its lead candidate FG-3019 (its in mid-stage trials for pulmonary fibrosis and liver fibrosis due to hepatitis B infection).

• [By John Udovich]

  While Intercept Pharmaceuticals Inc (NASDAQ: ICPT) surged earlier this year and Achillion Pharmaceuticals, Inc (NASDAQ: ACHN) has surged this week after Merck & Co. Inc (NYSE: MRK) agreed to purchase hepatitis stock�Idenix Pharmaceuticals Inc (NASDAQ: IDIX) at a 239% premium, it seems the herd has realized that small cap Conatus Pharmaceuticals Inc (NASDAQ: CNAT) is also a liver disease stock as shares suddenly surged 56.69% on no apparent company news. But just what is�Conatus Pharmaceuticals and is it worth taking a chance on?

• [By Lauren Pollock]

  Conatus Pharmaceuticals Inc.'s(CNAT) shares jumped 26% to $7.75 premarket after the biotechnology firm said its treatment for chronic liver disease has been granted a status that could mean quicker approval.

Top 5 Diversified Bank Companies To Own For 2014: ING Prime Rate Trust (PPR)

ING Prime Rate Trust (the Trust) is a diversified closed-end management investment company. The Trust seeks to provide a high a level of current income together with the preservation of capital. It invests least 80% of its net assets, plus the amount of any borrowings for investment purposes, in United States dollar-denominated, floating-rate secured senior loans. It also invests a substantial portion of its assets in below investment-grade senior loans and other below investment-grade assets.

The Trust invests in sectors, such as healthcare, education and childcare; cable; chemicals, plastics and rubber; utilities; printing and publishing; leisure, amusement and entertainment; oil and gas; retail stores; data and Internet services, and beverage, food and tobacco. The Trust�� investment advisor is ING Investments, LLC. ING Prime Rate Trust�� sub-advisor is ING Investment Management Co. and its administrator is ING Funds Services, LLC. ING Investments, LLC, ING Investment Management Co. and ING Funds Services, LLC are indirect, wholly owned subsidiaries of ING Groep N.V.

Advisors' Opinion:

• [By Aaron Levitt]

  The main reason why investors fled bounds during the taper tantrum is that bond prices have a negative correlation with rising interest rates. The ING Prime Rate Trust (PPR) avoids some of those problems.

• [By John Dowdee]

  The following 10 funds satisfied all of these conditions:

  BlackRock Float Rate Strategies (FRA). This CEF sells at a discount of 3%, which is low compared to an average premium of 2% over the past year. The distribution has been managed at 6.1% and a small amount (less than 10%) has been return of capital (ROC). However, this has not negatively affected net asset value (NAV) so has not been destructive. The fund holds 447 securities, with 90% in floating rate loans. FRA utilizes 27% leverage and has an expense ratio of 1.7%, including interest payments. Eaton Vance Floating Rate (EFR). This CEF sells at a 1% premium, which is low compared to an average premium of 5% over the past year. The distribution is 6.2%, none of which was ROC. The fund holds 800 securities, with 90% in floating rate loans. About 85% of the securities are from U.S. companies. EFR utilizes 35% leverage and has an expense ratio of 1.8% including interest payments. ING Prime Rate Trust (PPR). This CEF sells for a premium of 2%, which is below the average premium of 5%. It has a distribution of 6.8%, none of which was ROC. The fund has 350 holdings, virtually all in senior loans and from US companies. PPR utilizes 29% leverage and has a high expense ratio of 2.1%, including interest payments. Invesco VK Dynamic Credit Opportunities (VTA). This CEF sells for a discount of 5%, which is below the average discount of 1%. It has a distribution of 7.1%, none of which was ROC. The fund has 495 holdings, with 76% in floating rate loans. About 25% of the loans are from non-US companies. VTA utilizes a relatively low 20% leverage but still has a high expense ratio of 2.1%, including interest payments. Invesco VK Senior Income (VVR). This CEF sells for a discount of 1%, which is below the average premium of 3%. It has a distribution of 7.1%, none of which was ROC. The fund has over 500 holdings, with 89% in floating rate loans. Almost all (95%) securities are from US companies. VVR ut

Top 5 Diversified Bank Companies To Own For 2014: View Systems Inc (VSYM)

View Systems, Inc. (View Systems), incorporated on July 25, 2003, develops, produces and markets computer software and hardware systems for security and surveillance applications. The Company has penetrated four market segments for this product: correctional facilities, judicial facilities, probation offices and federal facilities in the Mid-Atlantic States, the West Coast and the South. The Company�� products and services include ViewScan Concealed Weapons Detection System, Multi-Mission Mobil Video (MMV), ViewMaxx Digital Video System, Additional Applications and Integration of ViewScan and ViewMaxx, the MINI, Network Services, FiberXpress, Inc., Visisys Ltd. and Training and Service Programs.

ViewScan Concealed Weapons Detection System

ViewScan is sold under the name Secure Scan, is a walk-through concealed weapons detector, which uses data sensing technology to pinpoint the location, size and number of concealed weapons. This walk-through portal is controlled by a master processing board and a personal computer based unit which receives magnetic and video information and combines it in a manner that allows the suspected location of the weapon to be stored electronically and referenced. ViewScan products are distributed in three basic configurations; stand-alone units, portable units and integrated door systems. ViewScan is designed to overcome the traditional shortcomings of electromagnetic induction scanners.

Multi-Mission Mobil Video

The MMV is a lightweight, wireless camera system housed in a tough, waterproof body. The camera system sends back real-time images to a computer or video monitor at the command post located outside the exclusion zone or containment area. The MMV also uses an Extension Link which is a separate transmitter and receiving system that increases the operating range of the MMV.

The Company has incorporated a video encryption feature that allows first responders to transmit on-scene video to the command post! without the data being intercepted by unwanted parties. The MMV is fully deployed by one person in a stand-alone configuration in less than 10 minutes. The system is battery operated and can operate for eight continuous hours using one set of spare camera batteries.

ViewMaxx Digital Video System

ViewMaxx is a high-resolution, digital video recording and real-time monitoring system. This system can be scaled to meet a specific customer's needs by using anywhere from one camera up to 32 surveillance cameras per each ViewMaxx unit. The system uses a video capture card recording which translates closed-circuit television analog video data (a format normally used by broadcasters for national television programs) to a computer readable digital format to be stored on direct access digital disk devices rather than the conventional television format of video tape. ViewMaxx offers programmable recording features that can eliminate the unnecessary storage of non-critical image data.

Additional Applications and Integration of ViewScan and ViewMaxx

The Company offers integration of other products with ViewScan or ViewMaxx. Its product can be interfaced with ViewScan and/or ViewMaxx to limit individual access to an area. ViewScan and/or ViewMaxx can be coupled with magnetic door locks to restrict access to a particular area. It also offers a central monitoring or video command center for ViewScan or ViewMaxx products.

The MINI

The MINI (Mobile Intelligent Network Informer) is a portable, wireless watchdog communication device that checks for intrusion into uninhabited areas such as foreclosed houses, storage spaces and vacation homes. The MINI senses motion and sends text messages to a user's cell phone. Property and remote assets may be guarded by this device that requires no plug-in electricity, no physical phone line and no monitoring service. The MINI runs on batteries and one configuration of the system can even send a photo of the in! truder to! the user's cell phone. Camera settings can be controlled and changed via short message service (SMS) commands. It licenses the MINI from its manufacturer and acts as a distributor.

Network Services

View Systems Inc. Network Services group supplied integrated electronic security and control systems. It supplied for commercial and industrial applications throughout the Mid Atlantic area.

FiberXpress, Inc.

FiberXpress, Inc. sells specialist data network related products. It sells its products through its Internet Website.

Visisys Ltd.

During the year ended December 31, 2011, there were no revenues from this partnership. The Company's partnership with Visisys, Ltd. has been terminated.

Training and Service Programs

The Company offers support services for our products, which includes on site consulting/planning with customer architect and engineers; installation and technical support; installation and technical support, and cand. The Company's family of products offers government and law enforcement agencies, commercial security professionals, private businesses and residential consumers an enhanced surveillance and detection capacity. Its ViewScan products and technology can be used where there is a temporary requirement for real-time weapons detection devices in areas where a permanent installation is prohibitive or impractical.

A primary market for the Company's ViewScan portal is federal and state government courthouses, county and municipal buildings, and correctional facilities. The Company has installed its ViewScan weapons detection products in a variety of court house situations. The MMV product's market includes National Guard units and first response agencies such as fire, police, SWAT, and homeland security response teams.

The Company competes with Ranger Security Scanners, Inc., Garrett Electronics, Inc., CEIA SpA, Sensormatic Corporation, NICE Systems, Ltd. and Inte! gral Syst! ems.

Advisors' Opinion:

• [By Bryan Murphy]

  It's tragic that it took a tragedy like last year's shooting at a Newton, Connecticut elementary school to get the ball rolling. Nevertheless, that ball is rolling now, and it's putting companies like L-3 Communications Holdings, Inc. (NYSE:LLL), View Systems Inc. (OTCBB:VSYM), and American Science & Engineering, Inc. (NASDAQ:ASEI) in the spotlight. How so? Because VSYM, ASEI, and LLL make the tools that are, unfortunately, going to be the only way to absolutely ensure this nation's public schools are secure, and defended from gunmen like Newton's Adam Lanza.

Top 5 Diversified Bank Companies To Own For 2014: FirstEnergy Corporation(FE)

Firstenergy Corp. operates as a diversified energy company. The company, through its subsidiaries and affiliates, involves in the generation, transmission, and distribution of electricity, as well as energy management and other energy-related services. It serves approximately 6 million customers within 67,000 square miles through 10 utility operating companies in Ohio, Pennsylvania, New Jersey, West Virginia and Maryland. The company was founded in 1996 and is headquartered in Akron, Ohio.

Advisors' Opinion:

• [By David Dittman]

  FirstEnergy Corp (NYSE: FE) is perhaps the riskiest play among the six stocks listed in the table. FirstEnergy is coming off a 34.5 percent dividend cut announced in January 2014 following a ��horough��study of the company�� businesses. The board concluded that a dividend rate ��ligned��with revenue and earnings generated by regulated operations ��ill provide the best path forward for FirstEnergy.��/p>

• [By Rich Duprey]

  Padlocking the front gate
  Yet it can't be denied that the demise of many plants has been hastened by the animus against the coal industry. In 2012 alone, Duke Energy (NYSE: DUK  ) retired eight coal plants representing 730 megawatts of capacity and�Dominion (NYSE: D  ) took down nine, eliminating 1.1 gigawatts of capacity. FirstEnergy (NYSE: FE  ) idled three for 500 megawatts.�SourceWatch says two dozen plants will be retired in 2013 representing 2.9 gigawatts of capacity with nearly 50 plants expected to close next year totaling seven gigawatts of capacity.�

• [By Justin Loiseau]

  Please, sir, I want some more
  Exelon (NYSE: EXC  ) filed renewal applications this week for two of its Illinois nuclear power stations. Collectively, the facilities generate more than 4,600 MW of electricity. That's 13% of the utility's total capacity and 24% of its nuclear capacity. For a peck of peer perspective, that's also more than FirstEnergy's (NYSE: FE  ) entire 3,990 MW nuclear capacity, which accounts for one-fifth of FirstEnergy's total generation.